Loew Caroline — SEC Form 4 filings

SEC reporting owner CIK 1989488. 7 Form 4 filings on record with FilingPulse; latest filed 2025-12-05.

Transaction summary — filings shown

Covers all 7 filings on record, filed 2024-03-04 to 2025-12-05. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Mural Oncology plc (MURA)Chief Executive Officer, Director74 legs · 32,138 sh · $90,8269

Form 4 filings — Loew Caroline

FiledFormIssuerReported transactionsSource
2025-12-054Mural Oncology plc (MURA)Disposition to issuer (D): 293,059 · Disposition to issuer (D): 379,690 (derivative) · Disposition to issuer (D): 90,025 (derivative) · Disposition to issuer (D): 134,225 (derivative)EDGAR
2025-07-094Mural Oncology plc (MURA)Sale (S): 12,531 @ $2.43EDGAR
2025-03-054Mural Oncology plc (MURA)Grant/award (A): 72,275 @ $0 · Sale (S): 4,313 @ $3.36 · Grant/award (A): 134,225 (derivative) @ $0EDGAR
2024-12-184Mural Oncology plc (MURA)Sale (S): 2,763 @ $3.40EDGAR
2024-07-084Mural Oncology plc (MURA)Sale (S): 12,531 @ $2.91EDGAR
2024-04-114/AMural Oncology plc (MURA)Grant/award (A): 379,690 (derivative)EDGAR
2024-03-044Mural Oncology plc (MURA)Grant/award (A): 48,475 @ $0 · Grant/award (A): 90,025 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1989488 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →